Whole brain delivery of an instability-prone Mecp2 transgene improves behavioral and molecular pathological defects in mouse models of Rett syndrome

  1. Mirko Luoni
  2. Serena Giannelli
  3. Marzia Tina Indrigo
  4. Antonio Niro
  5. Luca Massimino
  6. Angelo Iannielli
  7. Laura Passeri
  8. Fabio Russo
  9. Giuseppe Morabito
  10. Piera Calamita
  11. Silvia Gregori
  12. Benjamin Deverman
  13. Vania Broccoli  Is a corresponding author
  1. San Raffaele Scientific Institute, Italy
  2. National Institute of Molecular Genetics, Italy
  3. Stanley Center for Psychiatric Research at Broad Institute, United States

Abstract

Rett syndrome is an incurable neurodevelopmental disorder caused by mutations in the gene encoding for methyl-CpG binding-protein 2 (MeCP2). Gene therapy for this disease presents inherent hurdles since MECP2 is expressed throughout the brain and its duplication leads to severe neurological conditions as well. Herein, we use the AAV-PHP.eB to deliver an instability-prone Mecp2 (iMecp2) transgene cassette which, increasing RNA destabilization and inefficient protein translation of the viral Mecp2 transgene, limits supraphysiological Mecp2 protein levels. Intravenous injections of the PHP.eB-iMecp2 virus in symptomatic Mecp2 mutant mice significantly improved locomotor activity, lifespan and gene expression normalization. Remarkably, PHP.eB-iMecp2 administration was well tolerated in female Mecp2 mutant or in wild-type animals. In contrast, we observed a strong immune response to the transgene in treated male Mecp2 mutant mice that was overcome by immunosuppression. Overall, PHP.eB-mediated delivery of iMecp2 provided widespread and efficient gene transfer maintaining physiological Mecp2 protein levels in the brain.

Data availability

Sequencing data have been deposited in GEO under accession code GSE125155.

The following data sets were generated

Article and author information

Author details

  1. Mirko Luoni

    Division of Neuroscience, San Raffaele Scientific Institute, Milano, Italy
    Competing interests
    The authors declare that no competing interests exist.
  2. Serena Giannelli

    Division of Neuroscience, San Raffaele Scientific Institute, Milan, Italy
    Competing interests
    The authors declare that no competing interests exist.
  3. Marzia Tina Indrigo

    Division of Neuroscience, San Raffaele Scientific Institute, Milano, Italy
    Competing interests
    The authors declare that no competing interests exist.
  4. Antonio Niro

    Division of Neuroscience, San Raffaele Scientific Institute, Milano, Italy
    Competing interests
    The authors declare that no competing interests exist.
  5. Luca Massimino

    Division of Neuroscience, San Raffaele Scientific Institute, Milan, Italy
    Competing interests
    The authors declare that no competing interests exist.
  6. Angelo Iannielli

    Division of Neuroscience, San Raffaele Scientific Institute, Milan, Italy
    Competing interests
    The authors declare that no competing interests exist.
  7. Laura Passeri

    Institute for Gene Therapy (SR-Tiget), San Raffaele Scientific Institute, Milano, Italy
    Competing interests
    The authors declare that no competing interests exist.
  8. Fabio Russo

    Institute for Gene Therapy (SR-Tiget), San Raffaele Scientific Institute, Milano, Italy
    Competing interests
    The authors declare that no competing interests exist.
  9. Giuseppe Morabito

    Division of Neuroscience, San Raffaele Scientific Institute, Mialno, Italy
    Competing interests
    The authors declare that no competing interests exist.
  10. Piera Calamita

    National Institute of Molecular Genetics, Milano, Italy
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-9029-9346
  11. Silvia Gregori

    Institute for Gene Therapy (SR-Tiget), San Raffaele Scientific Institute, Milano, Italy
    Competing interests
    The authors declare that no competing interests exist.
  12. Benjamin Deverman

    Stanley Center for Psychiatric Research at Broad Institute, Cambridge, United States
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-6223-9303
  13. Vania Broccoli

    Division of Neuroscience, San Raffaele Scientific Institute, Milan, Italy
    For correspondence
    broccoli.vania@hsr.it
    Competing interests
    The authors declare that no competing interests exist.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-4050-0926

Funding

Fondazione Telethon (GGP19038)

  • Mirko Luoni

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Reviewing Editor

  1. Sonia Garel, Ecole Normale Superieure, France

Ethics

Animal experimentation: All procedures were performed according to protocols approved by the internal IACUC and reported to the Italian Ministry of Health according to the European Communities Council Directive 2010/63/EU.

Version history

  1. Received: October 10, 2019
  2. Accepted: March 23, 2020
  3. Accepted Manuscript published: March 24, 2020 (version 1)
  4. Version of Record published: April 2, 2020 (version 2)

Copyright

© 2020, Luoni et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 4,611
    views
  • 719
    downloads
  • 43
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Mirko Luoni
  2. Serena Giannelli
  3. Marzia Tina Indrigo
  4. Antonio Niro
  5. Luca Massimino
  6. Angelo Iannielli
  7. Laura Passeri
  8. Fabio Russo
  9. Giuseppe Morabito
  10. Piera Calamita
  11. Silvia Gregori
  12. Benjamin Deverman
  13. Vania Broccoli
(2020)
Whole brain delivery of an instability-prone Mecp2 transgene improves behavioral and molecular pathological defects in mouse models of Rett syndrome
eLife 9:e52629.
https://doi.org/10.7554/eLife.52629

Share this article

https://doi.org/10.7554/eLife.52629

Further reading

    1. Neuroscience
    Olivier Codol, Jonathan A Michaels ... Paul L Gribble
    Tools and Resources

    Artificial neural networks (ANNs) are a powerful class of computational models for unravelling neural mechanisms of brain function. However, for neural control of movement, they currently must be integrated with software simulating biomechanical effectors, leading to limiting impracticalities: (1) researchers must rely on two different platforms and (2) biomechanical effectors are not generally differentiable, constraining researchers to reinforcement learning algorithms despite the existence and potential biological relevance of faster training methods. To address these limitations, we developed MotorNet, an open-source Python toolbox for creating arbitrarily complex, differentiable, and biomechanically realistic effectors that can be trained on user-defined motor tasks using ANNs. MotorNet is designed to meet several goals: ease of installation, ease of use, a high-level user-friendly application programming interface, and a modular architecture to allow for flexibility in model building. MotorNet requires no dependencies outside Python, making it easy to get started with. For instance, it allows training ANNs on typically used motor control models such as a two joint, six muscle, planar arm within minutes on a typical desktop computer. MotorNet is built on PyTorch and therefore can implement any network architecture that is possible using the PyTorch framework. Consequently, it will immediately benefit from advances in artificial intelligence through PyTorch updates. Finally, it is open source, enabling users to create and share their own improvements, such as new effector and network architectures or custom task designs. MotorNet’s focus on higher-order model and task design will alleviate overhead cost to initiate computational projects for new researchers by providing a standalone, ready-to-go framework, and speed up efforts of established computational teams by enabling a focus on concepts and ideas over implementation.

    1. Neuroscience
    Meike E van der Heijden, Amanda M Brown ... Roy V Sillitoe
    Research Article

    The cerebellum contributes to a diverse array of motor conditions, including ataxia, dystonia, and tremor. The neural substrates that encode this diversity are unclear. Here, we tested whether the neural spike activity of cerebellar output neurons is distinct between movement disorders with different impairments, generalizable across movement disorders with similar impairments, and capable of causing distinct movement impairments. Using in vivo awake recordings as input data, we trained a supervised classifier model to differentiate the spike parameters between mouse models for ataxia, dystonia, and tremor. The classifier model correctly assigned mouse phenotypes based on single-neuron signatures. Spike signatures were shared across etiologically distinct but phenotypically similar disease models. Mimicking these pathophysiological spike signatures with optogenetics induced the predicted motor impairments in otherwise healthy mice. These data show that distinct spike signatures promote the behavioral presentation of cerebellar diseases.